Advanced Oncotherapy PLC Stock London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
May. 03 | Advanced Oncotherapy financing talks continue, funds delayed | AN |
Apr. 02 | Sareum ups retail offer; SThree nabs former ITV exec | AN |
Financials (USD)
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M |
---|---|---|---|---|---|
Net income 2020 | -25M | Net income 2021 | -29M | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M | Net Debt 2021 | 49.09M | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 14-08-26 | |
Director of Finance/CFO | - | 16-09-30 | |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 20-09-28 |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Hans von Celsing
BRD | Director/Board Member | 74 | 17-01-25 |
1st Jan change | Capi. | |
---|---|---|
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |